Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
June 1, 1984
Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation
L Corea, M Bentivoglio, P Verdecchia, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1984
Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man
C A Sorbini, V Grassi, C Tantucci, et al.
Cardiologia (Rome, Italy)
|
October 1, 1986
[Effects of enalapril on the mass and function of the left ventricle in hypertensive subjects]
L Corea, M Bentivoglio, S Berioli, et al.
American Heart Journal
|
January 1, 1990
Stable angina pectoris and controlled ischemia: what causes the abnormalities in whole blood filterability?
G Ciuffetti, M Mercuri, R Lombardini, et al.
Recenti Progressi in Medicina
|
March 1, 1973
[Clinical epidemiology of chronic obstructive lung diseases. Clinico-functional differentiation between chronic bronchitis and pulmonary emphysema]
V Grassi, G Casucci, N Marchesi, et al.
Bollettino Della Societa Italiana Di Cardiologia
|
January 1, 1976
[Adreno-sympathetic activity in chronic cor pulmonale and in chronic respiratory insufficiency]
C A Sorbini, E Agabiti, C De Fazio, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine
E Agabiti-Rosei, M L Muiesan, G Romanelli, et al.
Cardiology
|
January 1, 1983
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension
E Agabiti-Rosei, C Alicandri, M Beschi, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1982
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension
G Muiesan, E Agabiti-Rosei, M Castellano, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine
L Corea, O Cardoni, R Fogari, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
June 1, 1984
Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation
L Corea, M Bentivoglio, P Verdecchia, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1984
Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man
C A Sorbini, V Grassi, C Tantucci, et al.
Cardiologia (Rome, Italy)
|
October 1, 1986
[Effects of enalapril on the mass and function of the left ventricle in hypertensive subjects]
L Corea, M Bentivoglio, S Berioli, et al.
American Heart Journal
|
January 1, 1990
Stable angina pectoris and controlled ischemia: what causes the abnormalities in whole blood filterability?
G Ciuffetti, M Mercuri, R Lombardini, et al.
Recenti Progressi in Medicina
|
March 1, 1973
[Clinical epidemiology of chronic obstructive lung diseases. Clinico-functional differentiation between chronic bronchitis and pulmonary emphysema]
V Grassi, G Casucci, N Marchesi, et al.
Bollettino Della Societa Italiana Di Cardiologia
|
January 1, 1976
[Adreno-sympathetic activity in chronic cor pulmonale and in chronic respiratory insufficiency]
C A Sorbini, E Agabiti, C De Fazio, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine
E Agabiti-Rosei, M L Muiesan, G Romanelli, et al.
Cardiology
|
January 1, 1983
Relationships between plasma catecholamines, renin, age and blood pressure in essential hypertension
E Agabiti-Rosei, C Alicandri, M Beschi, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1982
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension
G Muiesan, E Agabiti-Rosei, M Castellano, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine
L Corea, O Cardoni, R Fogari, et al.
Page
of 8